Lancet 394(10193):121130 Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, hman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF (2017) Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Tirzepatide (brand name Zepbound) is an FDA-approved medication designed to help adults with obesity or weight-related medical conditions shed pounds and maintain weight loss
Clinical surveillance may therefore include micronutrient status panels alongside inflammatory and metabolic indices
When GLP-1 medications enter the body, they bind to the receptors in the brain and work in several ways to support metabolic health